 | • レポートコード：D0804-14958 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ボツリヌス中毒の世界市場を広く調査・分析し、今後の市場展望をまとめております。ボツリヌス中毒の種類別市場規模（抗生物質、抗毒素、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Microbiotix、AlphaVax、XOMA Corporation、Molecular Targeting Technologies、Morphotek ・地域別グローバル市場分析 2015年-2020年 ・ボツリヌス中毒の北米市場（アメリカ、カナダ、メキシコ） ・ボツリヌス中毒のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ボツリヌス中毒のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ボツリヌス中毒の南米市場（ブラジル、アルゼンチン） ・ボツリヌス中毒の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗生物質、抗毒素、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Botulism Illness market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Botulism Illness market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Botulism Illness market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Botulism Illness market has been segmented into:
Antibiotics
Antitoxins
Other
By Application, Botulism Illness has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Botulism Illness market presented in the report. This section sheds light on the sales growth of different regional and country-level Botulism Illness markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Botulism Illness market.
The report offers in-depth assessment of the growth and other aspects of the Botulism Illness market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Botulism Illness Market Share Analysis
Botulism Illness competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Botulism Illness sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Botulism Illness sales, revenue and market share for each player covered in this report.
The major players covered in Botulism Illness are:
Microbiotix
AlphaVax
XOMA Corporation
Molecular Targeting Technologies
Morphotek
Table of Contents
1 Botulism Illness Market Overview
1.1 Product Overview and Scope of Botulism Illness
1.2 Classification of Botulism Illness by Type
1.2.1 Global Botulism Illness Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Botulism Illness Revenue Market Share by Type in 2019
1.2.3 Antibiotics
1.2.4 Antitoxins
1.2.5 Other
1.3 Global Botulism Illness Market by Application
1.3.1 Overview: Global Botulism Illness Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Botulism Illness Market by Regions
1.4.1 Global Botulism Illness Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Botulism Illness (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Botulism Illness Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Botulism Illness Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Botulism Illness Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Botulism Illness Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Botulism Illness Status and Prospect (2015-2025)
2 Company Profiles
2.1 Microbiotix
2.1.1 Microbiotix Details
2.1.2 Microbiotix Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Microbiotix SWOT Analysis
2.1.4 Microbiotix Product and Services
2.1.5 Microbiotix Botulism Illness Revenue, Gross Margin and Market Share (2018-2019)
2.2 AlphaVax
2.2.1 AlphaVax Details
2.2.2 AlphaVax Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AlphaVax SWOT Analysis
2.2.4 AlphaVax Product and Services
2.2.5 AlphaVax Botulism Illness Revenue, Gross Margin and Market Share (2018-2019)
2.3 XOMA Corporation
2.3.1 XOMA Corporation Details
2.3.2 XOMA Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 XOMA Corporation SWOT Analysis
2.3.4 XOMA Corporation Product and Services
2.3.5 XOMA Corporation Botulism Illness Revenue, Gross Margin and Market Share (2018-2019)
2.4 Molecular Targeting Technologies
2.4.1 Molecular Targeting Technologies Details
2.4.2 Molecular Targeting Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Molecular Targeting Technologies SWOT Analysis
2.4.4 Molecular Targeting Technologies Product and Services
2.4.5 Molecular Targeting Technologies Botulism Illness Revenue, Gross Margin and Market Share (2018-2019)
2.5 Morphotek
2.5.1 Morphotek Details
2.5.2 Morphotek Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Morphotek SWOT Analysis
2.5.4 Morphotek Product and Services
2.5.5 Morphotek Botulism Illness Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Botulism Illness Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Botulism Illness Players Market Share
3.2.2 Top 10 Botulism Illness Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Botulism Illness Revenue and Market Share by Regions
4.2 North America Botulism Illness Revenue and Growth Rate (2015-2020)
4.3 Europe Botulism Illness Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Botulism Illness Revenue and Growth Rate (2015-2020)
4.5 South America Botulism Illness Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Botulism Illness Revenue and Growth Rate (2015-2020)
5 North America Botulism Illness Revenue by Countries
5.1 North America Botulism Illness Revenue by Countries (2015-2020)
5.2 USA Botulism Illness Revenue and Growth Rate (2015-2020)
5.3 Canada Botulism Illness Revenue and Growth Rate (2015-2020)
5.4 Mexico Botulism Illness Revenue and Growth Rate (2015-2020)
6 Europe Botulism Illness Revenue by Countries
6.1 Europe Botulism Illness Revenue by Countries (2015-2020)
6.2 Germany Botulism Illness Revenue and Growth Rate (2015-2020)
6.3 UK Botulism Illness Revenue and Growth Rate (2015-2020)
6.4 France Botulism Illness Revenue and Growth Rate (2015-2020)
6.5 Russia Botulism Illness Revenue and Growth Rate (2015-2020)
6.6 Italy Botulism Illness Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Botulism Illness Revenue by Countries
7.1 Asia-Pacific Botulism Illness Revenue by Countries (2015-2020)
7.2 China Botulism Illness Revenue and Growth Rate (2015-2020)
7.3 Japan Botulism Illness Revenue and Growth Rate (2015-2020)
7.4 Korea Botulism Illness Revenue and Growth Rate (2015-2020)
7.5 India Botulism Illness Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Botulism Illness Revenue and Growth Rate (2015-2020)
8 South America Botulism Illness Revenue by Countries
8.1 South America Botulism Illness Revenue by Countries (2015-2020)
8.2 Brazil Botulism Illness Revenue and Growth Rate (2015-2020)
8.3 Argentina Botulism Illness Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Botulism Illness by Countries
9.1 Middle East & Africa Botulism Illness Revenue by Countries (2015-2020)
9.2 Saudi Arabia Botulism Illness Revenue and Growth Rate (2015-2020)
9.3 UAE Botulism Illness Revenue and Growth Rate (2015-2020)
9.4 Egypt Botulism Illness Revenue and Growth Rate (2015-2020)
9.5 South Africa Botulism Illness Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Botulism Illness Revenue and Market Share by Type (2015-2020)
10.2 Global Botulism Illness Market Forecast by Type (2019-2024)
10.3 Antibiotics Revenue Growth Rate (2015-2025)
10.4 Antitoxins Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Botulism Illness Market Segment by Application
11.1 Global Botulism Illness Revenue Market Share by Application (2015-2020)
11.2 Botulism Illness Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Botulism Illness Market Size Forecast (2021-2025)
12.1 Global Botulism Illness Market Size Forecast (2021-2025)
12.2 Global Botulism Illness Market Forecast by Regions (2021-2025)
12.3 North America Botulism Illness Revenue Market Forecast (2021-2025)
12.4 Europe Botulism Illness Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Botulism Illness Revenue Market Forecast (2021-2025)
12.6 South America Botulism Illness Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Botulism Illness Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Botulism Illness Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Botulism Illness by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Botulism Illness Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Botulism Illness Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Microbiotix Corporate Information, Location and Competitors
Table 6. Microbiotix Botulism Illness Major Business
Table 7. Microbiotix Botulism Illness Total Revenue (USD Million) (2017-2018)
Table 8. Microbiotix SWOT Analysis
Table 9. Microbiotix Botulism Illness Product and Solutions
Table 10. Microbiotix Botulism Illness Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AlphaVax Corporate Information, Location and Competitors
Table 12. AlphaVax Botulism Illness Major Business
Table 13. AlphaVax Botulism Illness Total Revenue (USD Million) (2018-2019)
Table 14. AlphaVax SWOT Analysis
Table 15. AlphaVax Botulism Illness Product and Solutions
Table 16. AlphaVax Botulism Illness Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. XOMA Corporation Corporate Information, Location and Competitors
Table 18. XOMA Corporation Botulism Illness Major Business
Table 19. XOMA Corporation Botulism Illness Total Revenue (USD Million) (2017-2018)
Table 20. XOMA Corporation SWOT Analysis
Table 21. XOMA Corporation Botulism Illness Product and Solutions
Table 22. XOMA Corporation Botulism Illness Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Molecular Targeting Technologies Corporate Information, Location and Competitors
Table 24. Molecular Targeting Technologies Botulism Illness Major Business
Table 25. Molecular Targeting Technologies Botulism Illness Total Revenue (USD Million) (2017-2018)
Table 26. Molecular Targeting Technologies SWOT Analysis
Table 27. Molecular Targeting Technologies Botulism Illness Product and Solutions
Table 28. Molecular Targeting Technologies Botulism Illness Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Morphotek Corporate Information, Location and Competitors
Table 30. Morphotek Botulism Illness Major Business
Table 31. Morphotek Botulism Illness Total Revenue (USD Million) (2017-2018)
Table 32. Morphotek SWOT Analysis
Table 33. Morphotek Botulism Illness Product and Solutions
Table 34. Morphotek Botulism Illness Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Botulism Illness Revenue (Million USD) by Players (2015-2020)
Table 36. Global Botulism Illness Revenue Share by Players (2015-2020)
Table 37. Global Botulism Illness Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Botulism Illness Revenue Market Share by Regions (2015-2020)
Table 39. North America Botulism Illness Revenue by Countries (2015-2020)
Table 40. North America Botulism Illness Revenue Market Share by Countries (2015-2020)
Table 41. Europe Botulism Illness Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Botulism Illness Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Botulism Illness Revenue by Countries (2015-2020)
Table 44. South America Botulism Illness Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Botulism Illness Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Botulism Illness Revenue Market Share by Countries (2015-2020)
Table 47. Global Botulism Illness Revenue (Million USD) by Type (2015-2020)
Table 48. Global Botulism Illness Revenue Share by Type (2015-2020)
Table 49. Global Botulism Illness Revenue Forecast by Type (2021-2025)
Table 50. Global Botulism Illness Revenue by Application (2015-2020)
Table 51. Global Botulism Illness Revenue Share by Application (2015-2020)
Table 52. Global Botulism Illness Revenue Forecast by Application (2021-2025)
Table 53. Global Botulism Illness Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Botulism Illness Picture
Figure 2. Global Botulism Illness Revenue Market Share by Type in 2019
Figure 3. Antibiotics Picture
Figure 4. Antitoxins Picture
Figure 5. Other Picture
Figure 6. Botulism Illness Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Botulism Illness Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Botulism Illness Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Botulism Illness Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Botulism Illness Revenue Market Share in 2019
Figure 19. Global Top 10 Players Botulism Illness Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Botulism Illness Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Botulism Illness Revenue Market Share by Regions (2015-2020)
Figure 23. Global Botulism Illness Revenue Market Share by Regions in 2018
Figure 24. North America Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 25. Europe Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 27. South America Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 29. North America Botulism Illness Revenue Market Share by Countries (2015-2020)
Figure 30. North America Botulism Illness Revenue Market Share by Countries in 2019
Figure 31. USA Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 32. Canada Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 34. Europe Botulism Illness Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Botulism Illness Revenue Market Share by Countries in 2019
Figure 36. Germany Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 37. UK Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 38. France Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 39. Russia Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 40. Italy Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Botulism Illness Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Botulism Illness Revenue Market Share by Countries in 2019
Figure 43. China Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 44. Japan Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 45. Korea Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 46. India Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 48. South America Botulism Illness Revenue Market Share by Countries (2015-2020)
Figure 49. South America Botulism Illness Revenue Market Share by Countries in 2019
Figure 50. Brazil Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Botulism Illness Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Botulism Illness Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 55. UAE Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Botulism Illness Revenue and Growth Rate (2015-2020)
Figure 58. Global Botulism Illness Revenue Share by Type (2015-2020)
Figure 59. Global Botulism Illness Revenue Share by Type in 2019
Figure 60. Global Botulism Illness Market Share Forecast by Type (2021-2025)
Figure 61. Global Antibiotics Revenue Growth Rate (2015-2020)
Figure 62. Global Antitoxins Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Botulism Illness Revenue Share by Application (2015-2020)
Figure 65. Global Botulism Illness Revenue Share by Application in 2019
Figure 66. Global Botulism Illness Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Botulism Illness Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Botulism Illness Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Botulism Illness Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Botulism Illness Revenue Market Forecast (2021-2025)
Figure 74. Europe Botulism Illness Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Botulism Illness Revenue Market Forecast (2021-2025)
Figure 76. South America Botulism Illness Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Botulism Illness Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
重病保険の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Critical Illness Insurance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- ジバルプロエクスナトリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Divalproex Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- MRSA抗生物質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global MRSA Antibiotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The MRSA Antibiotics market repo…
- 腹膜膿瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Peritonsillar Abscess Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 腹膜膿瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Peritonsillar Abscess Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…